Comboval 10 mg/ml + 3 mg/ml, Solution pour perfusion

7680695680010 CH-69568 Infusionslösung
Comboval 10 mg/ml + 3 mg/ml, Solution pour perfusion
Comboval 10 mg/ml + 3 mg/ml, Solution pour perfusion
Comboval 10 mg/ml + 3 mg/ml, Solution pour perfusion
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Durchstechflasche(n)
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
02/09/2025
Summary of Product Characteristics
Français
02/09/2025
Summary of Product Characteristics
Italien
02/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
3.85 MG Substance WIZUS
(N/A)
3.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.424 MG Substance HBESI

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
69568
Drug name
Comboval, Solution pour perfusion
Galenic form
LSINF
ATC Code
N02BE51
Authorization status
Z
Dispensing category
B
First authorization
19/11/2024
Authorization expiration date
18/11/2029
IT Number
01.01.2.
Domain
Human medicine

Package details

Description (FR)
COMBOVAL sol perf 10 flac 100 ml
Description (DE)
COMBOVAL Inf Lös 10 Durchstf 100 ml
Market launch
19/11/2024
Narcotic (BTM)
No